Shakeel, S.; Iffat, W.; Qamar, A.; Rehman, H.; Ghuman, F.; Butt, F.; ur Rehman, A.; Madléna, M.; Paulik, E.; Gajdács, M.;
et al. Healthcare Professionals’ Compliance with the Standard Management Guidelines towards the Use of Biological Disease-Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis Patients. Int. J. Environ. Res. Public Health 2022, 19, 4699.
https://doi.org/10.3390/ijerph19084699
AMA Style
Shakeel S, Iffat W, Qamar A, Rehman H, Ghuman F, Butt F, ur Rehman A, Madléna M, Paulik E, Gajdács M,
et al. Healthcare Professionals’ Compliance with the Standard Management Guidelines towards the Use of Biological Disease-Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis Patients. International Journal of Environmental Research and Public Health. 2022; 19(8):4699.
https://doi.org/10.3390/ijerph19084699
Chicago/Turabian Style
Shakeel, Sadia, Wajiha Iffat, Ambreen Qamar, Hina Rehman, Faiza Ghuman, Fareeha Butt, Anees ur Rehman, Melinda Madléna, Edit Paulik, Márió Gajdács,
and et al. 2022. "Healthcare Professionals’ Compliance with the Standard Management Guidelines towards the Use of Biological Disease-Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis Patients" International Journal of Environmental Research and Public Health 19, no. 8: 4699.
https://doi.org/10.3390/ijerph19084699
APA Style
Shakeel, S., Iffat, W., Qamar, A., Rehman, H., Ghuman, F., Butt, F., ur Rehman, A., Madléna, M., Paulik, E., Gajdács, M., & Jamshed, S.
(2022). Healthcare Professionals’ Compliance with the Standard Management Guidelines towards the Use of Biological Disease-Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis Patients. International Journal of Environmental Research and Public Health, 19(8), 4699.
https://doi.org/10.3390/ijerph19084699